| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9458 |
| Human Intestinal Absorption | HIA+ | 0.8035 |
| Caco-2 Permeability | Caco2- | 0.6067 |
| P-glycoprotein Substrate | Non-substrate | 0.9319 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9430 |
| Non-inhibitor | 0.9962 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9493 |
| Distribution |
| Subcellular localization | Mitochondria | 0.4585 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8467 |
| CYP450 2D6 Substrate | Non-substrate | 0.8286 |
| CYP450 3A4 Substrate | Non-substrate | 0.7454 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8349 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8466 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9088 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8268 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9858 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9635 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.6316 |
| Non-inhibitor | 0.9369 |
| AMES Toxicity | Non AMES toxic | 0.8437 |
| Carcinogens | Carcinogens | 0.8565 |
| Fish Toxicity | Low FHMT | 0.8265 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.7593 |
| Honey Bee Toxicity | High HBT | 0.7906 |
| Biodegradation | Ready biodegradable | 0.9082 |
| Acute Oral Toxicity | III | 0.4968 |
| Carcinogenicity (Three-class) | Non-required | 0.6415 |